Federated Hermes, Inc. Genocea Biosciences, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $9 - $1,248	-905 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.96 - $1.35 $126 - $178	-132 Reduced 12.73%	905 $1,000
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.33 $1,804 - $2,416	1,037 New	1,037 $2,000
Q3 2019 Nov 14, 2019	SELL	$2.9 - $4.07 $986 - $1,383	-340 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $1,179 - $2,281	340 New	340 $1,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.